Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The awardees for the second round of the University of Oxford’s Enriching Engagement funding scheme have now been announced, including a project from Paediatrics.

Star-shaped trophy

Enriching Engagement is a Wellcome-funded grants programme open to Wellcome grant holders and awardees at the University of Oxford, to develop and deliver Public Engagement with Research projects. 

Round 2 awardees are:

  1. Dr Catherine Manning (Department of Experimental Psychology) -  "Sensory Street”
  2. Dr Jacinta O’Shea (Department of Psychiatry) - "Building stress resilience in early adolescence”
  3. Professor Anne Goriely (Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine) - “Me and my genome: What am I really made of?”
  4. Dr Carlo Rinaldi (Department of Paediatrics) - "Muscle Switch"
  5. Professor Jane Mckeating (Nuffield Department of Medicine) - "Understanding viruses: combining science and art to empower young people”
  6. Dr Anna Mitchell (Department of Experimental Psychology) - "APE: Animations and Public Engagement to promote transparency in primate neuroscience research”

Full details of each project are available on the University of Oxford website

Similar stories

University spinout PepGen awarded major financing to target Duchenne muscular dystrophy

Awards & Appointments Neuromuscular Diseases

PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.

Featured publication: Advances in oligonucleotide drug delivery

Neuromuscular Diseases Publication

Oligonucleotides - short DNA or RNA molecules - have great therapeutic application for a range of diseases. Yet, their potential has not been fully unleashed because of challenges linked to efficient delivery. Read more to find out about recent developments in oligonucleotide modifications, and the platforms that may be used to deliver them to target sites.

Typhoid vaccine project wins Vice-Chancellor award

Awards & Appointments Vaccinology

Congratulations to Professor Andrew Pollard who is the Winner of the Policy Engagement category in the Vice-Chancellor Innovation Awards 2020 for his work on Global policy on typhoid vaccines through research at Oxford!

Paediatrics project receives funding to assess novel coronavirus infection rates in children and teenagers across the UK

Awards & Appointments COVID-19 Vaccinology

A multi-site project, called ‘What’s the STORY?’ has received funding from UK Research and Innovation (UKRI) to assess novel coronavirus infection rates in children and teenagers across the UK. Given the importance of this study to the national Covid-19 response it has been deemed a priority study for the National Institute for Health Research’s (NIHR) Urgent Public Health Response.

Funding for new COVID-19 studies awarded to OVG's project on infectious disease immunity in children

Awards & Appointments COVID-19 Research Vaccinology

Five projects from across Oxford University's Medical Sciences Division, including a project led by Professor Matthew Snape from the Oxford Vaccine Group, are among twenty-one new studies into the novel coronavirus which have been funded by the UK government.

Communicating the messages of extracellular vesicles to the wider public

Public Engagement

Wood Group researchers in the Department of Paediatrics collaborate with DPAG's Denis Noble to produce innovative podcast talks on a prominent global platform, the Future Tech Podcast. Following the release of the final podcast talk in February 2020, we chart the story leading to these innovative pieces of public engagement.